Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNT-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials

Buch M. H.; Johnsen A.; Schiff M.

首页> 外文期刊>Clinical and experimental rheumatology >Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNT-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials

【24h】

Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNT-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials

机译：可以切换到类风湿性关节炎患者甲氨蝶呤甲氨蝶呤逆转TNT-抑制剂诱导的抗炎性自身抗体/双链DNA自身抗体转化患者分析充足和认可的试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective

机译：客观的

著录项

来源
《Clinical and experimental rheumatology》 |2019年第1期|共6页
作者
Buch M. H.; Johnsen A.; Schiff M.;
展开▼
作者单位

Univ Leeds Fac Med &

Hlth Leeds Inst Rheumat &

Musculoskeletal Med Leeds W Yorkshire England;

Bristol Myers Squibb Co Global Clin Res Immunosci Special Dev Princeton NJ USA;

Univ Colorado Dept Rheumatol Denver CO 80202 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
autoantibodies; tumour necrosis factor-alpha/antagonists and inhibitors; biologic agents; disease-modifying anti-rheumatic drugs; rheumatoid arthritis;

机译：自身抗体;肿瘤坏死因子 - α/拮抗剂和抑制剂;生物学剂;疾病改性抗风湿药物;类风湿性关节炎;
入库时间 2022-08-19 23:59:54

相似文献

外文文献
中文文献

1. Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNT-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials [J] . Buch M. H., Johnsen A., Schiff M. Clinical and experimental rheumatology . 2019,第1期

机译：可以切换到类风湿性关节炎患者甲氨蝶呤甲氨蝶呤逆转TNT-抑制剂诱导的抗炎性自身抗体/双链DNA自身抗体转化患者分析充足和认可的试验
2. Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis [J] . ScarsiM., PaoliniL., RicottaD., The Journal of rheumatology . 2014,第4期

机译：Abatacept降低类风湿关节炎患者的记忆开关B细胞，自身抗体和免疫球蛋白水平
3. The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial. [J] . Schiff M, Pritchard C, Huffstutter JE Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2009,第11期

机译：类风湿性关节炎患者在抗肿瘤坏死因子治疗后接受冲洗或直接转为使用abatacept的6个月安全性和有效性：ARRIVE试验。
4. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III multi-centre randomised double-blind placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate [O] . M Schiff, M Keiserman, C Codding, -1

机译：Abatacept或英夫利昔单抗与安慰剂在ATTEST中的疗效和安全性：类风湿关节炎患者对甲氨蝶呤反应不足的III期多中心随机双盲安慰剂对照研究
5. 088 Can Anti-Tumour Necrosis Factor–Induced Autoantibody Conversion be Reversed by Switching to Abatacept Therapy in Patients with Rheumatoid Arthritis on Background Methotrexate? [O] . 2016

机译：088可以通过切换对背景甲氨蝶呤的类风湿性关节炎患者的患者进行萎缩治疗来逆转抗肿瘤坏死因子诱导的自身抗体转化吗？

Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNT-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials

摘要

著录项

相似文献

相关主题

期刊订阅